Literature DB >> 18327662

Central role of dendritic cells in the regulation and deregulation of immune responses.

F Granucci1, I Zanoni, P Ricciardi-Castagnoli.   

Abstract

Dendritic cells (DCs) play a critical role in orchestrating the innate and adaptive components of the immune system so that appropriate, coordinated responses are mounted against infectious agents. Tissue-resident DCs interact with microbes through germline-encoded pattern-recognition receptors (PRRs), which recognize molecular patterns expressed by various microorganisms. Antigens use PRR activation to instruct DCs for the appropriate priming of natural killer (NK) cells, followed by specific T-cell responses. Due to the central role of DCs in regulating the activation and progression of immune responses, minor imbalances in the feedback control of Toll-like receptor (TLR)-activated cells have been associated with autoimmunity in genetically prone individuals. We review here recent findings on the role of DCs in the priming of innate and adaptive immune responses and the possible involvement of DCs in inducing and maintaining autoimmune reactions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18327662     DOI: 10.1007/s00018-008-8009-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  20 in total

Review 1.  Fibrosis--a lethal component of systemic sclerosis.

Authors:  Yuen Yee Ho; David Lagares; Andrew M Tager; Mohit Kapoor
Journal:  Nat Rev Rheumatol       Date:  2014-04-22       Impact factor: 20.543

2.  Use of single chain antibody derivatives for targeted drug delivery.

Authors:  Yaghoub Safdari; Vahideh Ahmadzadeh; Masoumeh Khalili; Hossein Zarei Jaliani; Vahid Zarei; Vahid Erfani-Moghadam
Journal:  Mol Med       Date:  2016-04-22       Impact factor: 6.354

3.  A dairy bacterium displays in vitro probiotic properties for the pharyngeal mucosa by antagonizing group A streptococci and modulating the immune response.

Authors:  Simone Guglielmetti; Valentina Taverniti; Mario Minuzzo; Stefania Arioli; Ivan Zanoni; Milda Stuknyte; Francesca Granucci; Matti Karp; Diego Mora
Journal:  Infect Immun       Date:  2010-08-23       Impact factor: 3.441

4.  TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection.

Authors:  Ivett Jelinek; Joshua N Leonard; Graeme E Price; Kevin N Brown; Anna Meyer-Manlapat; Paul K Goldsmith; Yan Wang; David Venzon; Suzanne L Epstein; David M Segal
Journal:  J Immunol       Date:  2011-01-17       Impact factor: 5.422

5.  The peptide sequence of diacyl lipopeptides determines dendritic cell TLR2-mediated NK activation.

Authors:  Masahiro Azuma; Ryoko Sawahata; Yuusuke Akao; Takashi Ebihara; Sayuri Yamazaki; Misako Matsumoto; Masahito Hashimoto; Koichi Fukase; Yukari Fujimoto; Tsukasa Seya
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

Review 6.  Dendritic cell-based human immunodeficiency virus vaccine.

Authors:  C R Rinaldo
Journal:  J Intern Med       Date:  2009-01       Impact factor: 8.989

Review 7.  Insights into the apoptotic death of immune cells in sepsis.

Authors:  Ying-yi Luan; Yong-ming Yao; Xian-zhong Xiao; Zhi-yong Sheng
Journal:  J Interferon Cytokine Res       Date:  2014-07-09       Impact factor: 2.607

Review 8.  Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists.

Authors:  Matthew Black; Amanda Trent; Matthew Tirrell; Colleen Olive
Journal:  Expert Rev Vaccines       Date:  2010-02       Impact factor: 5.217

9.  Isolation and phenotyping of normal mouse liver dendritic cells by an improved method.

Authors:  Ghasem Mosayebi; Sayyed Mohammad Moazzeni
Journal:  Iran J Basic Med Sci       Date:  2011-07       Impact factor: 2.699

Review 10.  Understanding dendritic cells and their role in cutaneous carcinoma and cancer immunotherapy.

Authors:  Valerie R Yanofsky; Hiroshi Mitsui; Diane Felsen; John A Carucci
Journal:  Clin Dev Immunol       Date:  2013-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.